contact@asploro.com

Diabetes and chronic inflammation for future research development | Abstract

Hiroshi Bando1,2

1Tokushima University / Medical Research, Tokushima, Japan

2Japan Low Carbohydrate Diet Promotion Association, Kyoto, Japan

Corresponding Author: Hiroshi Bando, MD, PhD, FACP

Address: Tokushima University/Medical Research, Nakashowa 1-61, Tokushima-770-0943, Japan; E-mail: pianomed@bronze.ocn.ne.jp

Received date: 15 August 2019; Accepted date: 17 August 2019; Published date: 26 August 2019

Editorial

Congratulations on the inaugural issue of Diabetes Research: Open Access (DROA). Across the world, the necessity of medical practice and research concerning diabetes has been more emphasized. The significant role of this journal will be expected from now.

In recent years, lifestyle-related diseases such as obesity and diabetes have increased worldwide as non-communicable diseases (NCDs). Statistically, 71% of 57 million world deaths in 2016 were from NCDs [1]. The United Nations meeting on NCSs reviewed the global progress for the prevention and control of NCDs, and proposed countdown 2030 for reduction of the burden of NCDs [1]. Among NCDs, diabetes and hypertension have been prevalent and important to manage in the clinical practice [2].

Citation: Bando H. Diabetes and chronic inflammation for future research development. Diab Res. 2019 Aug 26;1(1):1-4.

Copyright © 2019 Hiroshi Bando. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Key Words: Diabetes Research: Open Access (DROA); Non-Communicable Diseases (NCDs); Lifestyle-Related Diseases; Damage-Associated Molecular Patterns (DMAPs); Chronic Inflammation; Adipose Tissue

asploro

Asploro Open Access Publications Limited